ESC 365 - Cardiomyopathy development following breast cancer treatment: restratification.

ESC Premium Access

Cardiomyopathy development following breast cancer treatment: restratification.

Session: Mechanisms of Chemotherapy-Induced Cardiotoxicity

Topic: Basic Science, Other

Speaker: Doctor J. Moslehi (San Francisco, US)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Javid Moslehi

UCSF Medical Centre, San Francisco (United States of America)

12 presentations

0 follower

3 more presentations in this session

JAK-STAT signaling in preclinical cancer models and their impact on the heart.

Speaker: Professor D. Hilfiker-Kleiner (Hannover, DE)

iPS cells for testing and preventing cardiotoxicity.

Speaker: Professor M. Mercola (Stanford, US)

Chemotherapy-induced arrhythmias: how to identify and prevent them.

Speaker: Professor J. Hulot (Paris, FR)

Access the full session

Mechanisms of Chemotherapy-Induced Cardiotoxicity

Speakers: Doctor J. Moslehi, Professor D. Hilfiker-Kleiner, Professor M. Mercola, Professor J. Hulot

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources